First Time Loading...

AC Immune SA
NASDAQ:ACIU

Watchlist Manager
AC Immune SA Logo
AC Immune SA
NASDAQ:ACIU
Watchlist
Price: 2.35 USD 2.62% Market Closed
Updated: Apr 27, 2024

Wall Street
Price Targets

ACIU Price Targets Summary
AC Immune SA

Wall Street analysts forecast ACIU stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACIU is 10.71 USD with a low forecast of 6.57 USD and a high forecast of 16.8 USD.

Lowest
Price Target
6.57 USD
179% Upside
Average
Price Target
10.71 USD
356% Upside
Highest
Price Target
16.8 USD
615% Upside
AC Immune SA Competitors:
Price Targets
603387
Getein Biotech Inc
314% Upside
300149
ChemPartner PharmaTech Co Ltd
202% Upside
4891
TMS Co Ltd
216% Upside
XOMA
XOMA Corp
197% Upside
MLYS
Mineralys Therapeutics Inc
191% Upside
4974
Takara Bio Inc
101% Upside
048530
iNtRON Biotechnology Inc
138% Upside
KOD
Kodiak Sciences Inc
32% Upside

Revenue
Forecast

Revenue Estimate
AC Immune SA

For the last 8 years the compound annual growth rate for AC Immune SA's revenue is -11%. The projected CAGR for the next 3 years is 90%.

-11%
Past Growth
90%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
AC Immune SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
AC Immune SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-23%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACIU's stock price target?
Price Target
10.71 USD

According to Wall Street analysts, the average 1-year price target for ACIU is 10.71 USD with a low forecast of 6.57 USD and a high forecast of 16.8 USD.

What is AC Immune SA's Revenue forecast?
Projected CAGR
90%

For the last 8 years the compound annual growth rate for AC Immune SA's revenue is -11%. The projected CAGR for the next 3 years is 90%.